Streetbeat News

Stock Prices

JBLU

RTX

JetBlue Airways CEO has stated that the company's revenue growth has not been sufficient to outpace cost challenges. Additionally, Pratt & Whitney engine-related aircraft groundings are significantly impeding JetBlue's growth rate and pressuring profitability.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:15 pm

PSX

Phillips 66 shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:14 pm

CPRX

VRDN

VRNA

As of July 30, 2024, three health care stocks—Verona Pharma (VRNA), Catalyst Pharmaceuticals (CPRX), and Viridian Therapeutics (VRDN)—are considered overbought based on their RSI values. Investors may want to reconsider holding these stocks in the short term.

Portfolio Pulse from Avi Kapoor

July 30, 2024 | 2:13 pm

SBUX

Starbucks Corporation (NASDAQ:SBUX) is expected to report lower Q3 earnings, with analysts forecasting earnings of 93 cents per share, down from $1 per share last year. Revenue is projected at $9.24 billion. Several analysts have revised their price targets downward, maintaining neutral or hold ratings. Elliott Investment Management has taken a significant stake in the company.

Portfolio Pulse from Avi Kapoor

July 30, 2024 | 2:13 pm

MRK

Merck is targeting next year's RSV season in the U.S. for the release of its RSV antibody, as stated by a company executive during a conference call.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:13 pm

ATPC

CNSP

IMNN

NIPG

PCSA

PFE

QXO

U.S. stocks traded mostly higher with the Dow Jones gaining around 200 points. Pfizer reported better-than-expected Q2 earnings and updated its 2024 revenue and EPS forecasts. Imunon, Agape ATP, and Processa Pharmaceuticals saw significant stock price increases, while QXO, NIP Group, and CNS Pharmaceuticals experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 30, 2024 | 2:12 pm

ECL

Ecolab shares are trading lower after the company reported worse-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:12 pm

NIPG

NIP Group has resumed trading of its shares after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:10 pm

VBIV

Trading halt status for VBIV was updated at 10:10:00 AM ET. The article mentions news and resumption times for the stock.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:10 pm

CR

Crane shares are trading higher after the company reported better-than-expected Q2 financial results and raised the midpoint of its FY24 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 2:09 pm